- 30+ years pioneer in oncology drug development
- Distinguished Professor, Translational Genomics Research Institute and City of Hope
- Professor of Medicine at Mayo Clinic
- Former National Cancer Advisory Board Member
- Past President of the American Association for Cancer Research
- Contributed to development of Abraxane®(nab-paclitaxel), Camptosar® irinotecan, Gemzar® gemcitabine, Nal-IRI® (nanoliposomal irintotecan), TURALIO® (pexidartinab), and many others
